BARCLAYS PLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$134
-99.7%
6,163
+207.7%
0.00%
Q3 2022$39,000
+129.4%
2,003
+131.6%
0.00%
Q2 2022$17,000
-79.8%
865
-69.3%
0.00%
Q1 2022$84,000
-91.2%
2,817
-93.1%
0.00%
Q4 2021$954,000
+339.6%
40,960
+488.8%
0.00%
Q3 2021$217,000
+161.4%
6,957
+195.0%
0.00%
Q2 2021$83,000
-87.0%
2,358
-87.0%
0.00%
Q1 2021$637,000
+81.0%
18,070
+92.7%
0.00%
Q4 2020$352,000
+5.4%
9,377
-6.4%
0.00%
Q3 2020$334,000
+71.3%
10,015
+36.9%
0.00%
Q2 2020$195,000
+186.8%
7,316
+75.6%
0.00%
Q1 2020$68,000
-75.5%
4,166
-61.7%
0.00%
Q4 2019$277,000
+158.9%
10,885
+102.9%
0.00%
Q3 2019$107,000
-50.2%
5,364
-19.4%
0.00%
Q2 2019$215,000
+150.0%
6,658
+148.8%
0.00%
Q1 2019$86,000
+2050.0%
2,676
+1649.0%
0.00%
Q4 2018$4,000
-96.6%
153
-95.7%
0.00%
Q3 2018$117,000
+408.7%
3,528
+428.9%
0.00%
Q2 2018$23,000
-88.0%
667
-88.7%
0.00%
Q1 2018$192,000
+11.6%
5,893
-12.0%
0.00%
Q4 2017$172,0006,7000.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 480,000$14,318,0009.25%
Decheng Capital Management III (Cayman), LLC 518,342$15,462,0004.74%
TANG CAPITAL MANAGEMENT LLC 467,702$13,952,0002.79%
Birchview Capital, LP 113,000$3,371,0002.43%
Privium Fund Management B.V. 351,805$10,494,0002.32%
Sio Capital Management, LLC 144,546$4,312,0001.43%
Perceptive Advisors 2,360,139$70,403,0001.41%
Chicago Capital, LLC 1,011,744$30,180,0001.30%
Endurant Capital Management LP 120,834$3,604,0000.95%
Nicholas Investment Partners, LP 439,235$13,102,0000.93%
View complete list of ALBIREO PHARMA INC shareholders